The treatment of Alzheimer's Disease & Gout with vitamins

Alzheimer's Disease and Gout: Mitamins custom make quality formulas for the treatment of Alzheimer's Disease & Gout with vitamins. A Alzheimer's Disease & Gout formula will be made to suit you, using quality brand name ingredients. Mitamins produce custom made vitamin and supplement formulas to suit your individual health needs conveniently in one formula, one bottle and one dosage. For assistance, call toll free: 1-866-585-1390
Your Supplements Facts - Covers the formulas above
Supplement Facts

Specially Formulated for: Alzheimer's Disease and Gout

  • Amount Per Serving
    % DV
    Vitamin C
    200
    mg
    333%
    Vitamin E
    200
    IU
    667%
    Thiamin
    50
    mg
    3333%
    Folate
    400
    mcg
    100%
    Vitamin B12
    125
    mcg
    2083%
    Flax Seed Powder
    50
    mg
    *
    Blueberry Extract
    50
    mg
    *
  • Amount Per Serving
    % DV
    Ginkgo Extract
    40
    mg
    *
    Nettle Extract
    50
    mg
    *
    Quercetin
    100
    mg
    *
    Acetyl L-Carnitine
    250
    mg
    *
    Phosphatidylserine
    100
    mg
    *
    Bromelain
    100
    mg
    *
    * Daily Value (DV) not established
Name Your Supplement Bottle - Just how you like it
The current default name is: 
 
(Click in box to change)
Your Perfect Supplement - Custom-made just for you
Formulas form 35 Years of Medical Practice
Alzheimer's Disease and Gout
Serving Size:4-5

Alzheimer's Disease and Gout Formulas Details

Customize Your Supplements - Check all that apply
4A Select additional condition(s) you want to address:


4B Select all the medication(s) you are taking:
If your concern or medication is not listed here, use our Formulator, which covers 680 concerns and 1600 drugs, Click here!
Latest Health Related News:
Drug Combo Blocks Pain Without Impairing Movement (HealthDay)
A visit to the dentist could one day involve no pain and no numbness, Harvard researchers report.
Lupus Foundation Of America Statement On Results For Clinical Study Of CellCept(R) Released By Aspreva Pharmaceutical Company
The Lupus Foundation of America, Inc. and more than 1.5 million Americans with lupus have been awaiting the preliminary findings of the Phase III clinical trials for CellCept(R), a potential treatment for lupus kidney disease being tested by Aspreva Pharmaceutical Company.
This information concerning the support of Alzheimer's Disease and Gout treatments provide basic knowledge which should always be discussed with your own health practitioner.
Any Questions, Call Us Toll Free: 1-866-585-1390
Live Chat System

manufactured In USA

  verisign          Trust E Finalmark

Custom Vitamins and Nutritional Supplements for Supporting Age-Related Cognitive Decline and Aging Treatments